BioMarin Pharmaceutical
BMRN
#1736
Rank
C$16.05 B
Marketcap
C$83.59
Share price
3.14%
Change (1 day)
-12.25%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: C$16.05 Billion

As of December 2025 BioMarin Pharmaceutical has a market cap of C$16.05 Billion. This makes BioMarin Pharmaceutical the world's 1736th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2025

End of year Market Cap

Year Marketcap Change
2025C$16.05 B-12.21%
2024C$18.29 B-24.06%
2023C$24.08 B-7.7%
2022C$26.09 B26.25%
2021C$20.67 B1.85%
2020C$20.29 B2.21%
2019C$19.85 B-3.95%
2018C$20.67 B5.01%
2017C$19.68 B2.83%
2016C$19.14 B-18.43%
2015C$23.47 B50.08%
2014C$15.64 B45.58%
2013C$10.74 B74.55%
2012C$6.15 B54.1%
2011C$3.99 B34.12%
2010C$2.97 B49.04%
2009C$1.99 B-7.51%
2008C$2.16 B-37%
2007C$3.42 B95.93%
2006C$1.75 B87.7%
2005C$0.93 B88.37%
2004C$0.49 B-23.35%
2003C$0.64 B7.84%
2002C$0.59 B-46.62%
2001C$1.12 B109.36%
2000C$0.53 B-9.22%
1999C$0.59 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of BioMarin Pharmaceutical was reported to be:

C$16.05 Billion
by Nasdaq info icon info icon
C$16.05 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$4.50 B-71.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.19 B-98.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.25 B-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$160.06 B 896.68%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
C$6.00 B-62.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.07 B-74.64%๐Ÿ‡บ๐Ÿ‡ธ USA